HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Double blind controlled trial of deanol in tardive dyskinesia.

Abstract
Thirty three chronic psychiatric hospital subjects with oral tardive dyskinesia were divided into three groups. The subjects were matched for severity of symptoms then randomly assigned to treatment with a placebo, 1 g deanol or 2 g deanol per day. Statistical analysis showed that after 30 days treatment, there was a significant reduction in the mean rating of the movements of the group of 11 subjects on 2 g deanol per day. Six of these subjects showed substantial reduction in movement. Further studies using this dosage of deanol are unwarranted.
AuthorsJ George, S Pridmore, D Aldous
JournalThe Australian and New Zealand journal of psychiatry (Aust N Z J Psychiatry) Vol. 15 Issue 1 Pg. 68-71 (Mar 1981) ISSN: 0004-8674 [Print] England
PMID6942835 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Ethanolamines
  • Deanol
Topics
  • Aged
  • Deanol (therapeutic use)
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Dyskinesia, Drug-Induced (drug therapy)
  • Ethanolamines (therapeutic use)
  • Female
  • Humans
  • Male
  • Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: